Market closedNon-fractional

QuidelOrtho Corporation/QDEL

13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX

About QuidelOrtho Corporation

QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if the revenue from North America.

Ticker

QDEL

Sector

Healthcare

Trading on

NASDAQ

Industry

Health Care Equipment and Supplies

Headquarters

San Diego, United States

Employees

7,100

QDEL Metrics

BasicAdvanced
$2.1B
Market cap
-
P/E ratio
-$26.39
EPS
0.17
Beta
-
Dividend rate
$2.1B
0.17
1.555
0.712
73.247
78.118
0.87%
1.32%
-42.51%
0.73
0.63
-6.67
-17.67
-7.95%
-1,519.71%
15.41%
6.68%

What the Analysts think about QDEL

Analyst Ratings

Majority rating from 7 analysts.
Hold

QDEL Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-239.94% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$711M
-4.26%
Net income
-$1.7B
-24,471.43%
Profit margin
-239.94%
-25,625.53%

QDEL Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 12.61%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.26
$0.90
$1.17
$0.44
-
Expected
$0.28
$0.60
$2.05
$0.39
-$0.22
Surprise
-6.98%
50.75%
-42.87%
12.61%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for QuidelOrtho Corporation stock?

QuidelOrtho Corporation (QDEL) has a market cap of $2.1B as of July 05, 2024.

What is the P/E ratio for QuidelOrtho Corporation stock?

The price to earnings (P/E) ratio for QuidelOrtho Corporation (QDEL) stock is 0 as of July 05, 2024.

Does QuidelOrtho Corporation stock pay dividends?

No, QuidelOrtho Corporation (QDEL) stock does not pay dividends to its shareholders as of July 05, 2024.

When is the next QuidelOrtho Corporation dividend payment date?

QuidelOrtho Corporation (QDEL) stock does not pay dividends to its shareholders.

What is the beta indicator for QuidelOrtho Corporation?

QuidelOrtho Corporation (QDEL) has a beta rating of 0.17. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell QuidelOrtho Corporation stock

Buy or sell QuidelOrtho Corporation stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing